25^th World Biotechnology Congress

CRISPR Based Technologies and Bio-products

Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.